A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid Tumors
Clinical trial NCT00909740 · COMPLETED
Trial details
- NCT number
- NCT00909740
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-22
- Primary completion
- 2011-10-26
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.